These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12429038)

  • 1. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo.
    Cornish J; Callon KE; Bava U; Lin C; Naot D; Hill BL; Grey AB; Broom N; Myers DE; Nicholson GC; Reid IR
    J Endocrinol; 2002 Nov; 175(2):405-15. PubMed ID: 12429038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal phenotype of the leptin receptor-deficient db/db mouse.
    Williams GA; Callon KE; Watson M; Costa JL; Ding Y; Dickinson M; Wang Y; Naot D; Reid IR; Cornish J
    J Bone Miner Res; 2011 Aug; 26(8):1698-709. PubMed ID: 21328476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats.
    Tamasi JA; Arey BJ; Bertolini DR; Feyen JH
    J Bone Miner Res; 2003 Sep; 18(9):1605-11. PubMed ID: 12968669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of adiponectin on bone.
    Williams GA; Wang Y; Callon KE; Watson M; Lin JM; Lam JB; Costa JL; Orpe A; Broom N; Naot D; Reid IR; Cornish J
    Endocrinology; 2009 Aug; 150(8):3603-10. PubMed ID: 19406946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha -melanocyte-stimulating hormone is a novel regulator of bone.
    Cornish J; Callon KE; Mountjoy KG; Bava U; Lin JM; Myers DE; Naot D; Reid IR
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1181-90. PubMed ID: 12618359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells.
    Hoebertz A; Meghji S; Burnstock G; Arnett TR
    FASEB J; 2001 May; 15(7):1139-48. PubMed ID: 11344082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.
    Ducy P; Amling M; Takeda S; Priemel M; Schilling AF; Beil FT; Shen J; Vinson C; Rueger JM; Karsenty G
    Cell; 2000 Jan; 100(2):197-207. PubMed ID: 10660043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin as an endocrine signal in bone.
    Lee NJ; Wong IP; Baldock PA; Herzog H
    Curr Osteoporos Rep; 2008 Jun; 6(2):62-6. PubMed ID: 18778565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy regulation by the skeleton.
    Wolf G
    Nutr Rev; 2008 Apr; 66(4):229-33. PubMed ID: 18366536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of bone cell function by RANKL and OPG in different in vitro models.
    Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
    Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone mass regulation by leptin: a hypothalamic control of bone formation].
    Elefteriou F; Karsenty G
    Pathol Biol (Paris); 2004 Apr; 52(3):148-53. PubMed ID: 15063934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers.
    Maor G; Rochwerger M; Segev Y; Phillip M
    J Bone Miner Res; 2002 Jun; 17(6):1034-43. PubMed ID: 12054158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Leptin on the Skeleton.
    Reid IR; Baldock PA; Cornish J
    Endocr Rev; 2018 Dec; 39(6):938-959. PubMed ID: 30184053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is leptin the link between fat and bone mass?
    Isaia GC; D'Amelio P; Di Bella S; Tamone C
    J Endocrinol Invest; 2005; 28(10 Suppl):61-5. PubMed ID: 16550725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of osteoclastogenesis by fatty acids.
    Cornish J; MacGibbon A; Lin JM; Watson M; Callon KE; Tong PC; Dunford JE; van der Does Y; Williams GA; Grey AB; Naot D; Reid IR
    Endocrinology; 2008 Nov; 149(11):5688-95. PubMed ID: 18617622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of peripherally administered leptin antagonist on whole body metabolism and bone microarchitecture and biomechanical properties in the mouse.
    Solomon G; Atkins A; Shahar R; Gertler A; Monsonego-Ornan E
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(1):E14-27. PubMed ID: 24169045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification.
    Kishida Y; Hirao M; Tamai N; Nampei A; Fujimoto T; Nakase T; Shimizu N; Yoshikawa H; Myoui A
    Bone; 2005 Nov; 37(5):607-21. PubMed ID: 16039170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin: brains and bones.
    Whitfield JF
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1617-22. PubMed ID: 11772271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.